catalyst

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerabilit — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2025-10-06 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerabilit — primary completion
Type
Trial Readout
Date
2025-10-06
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder
trial